Induced Pluripotent Stem Cells Market to witness fastest growth by 2026
Induced Pluripotent Stem Cells Market Outlook 2019-2026:
Global Induced
Pluripotent Stem Cells Market key players are Fujifilm Holding Corporation,
Astellas Pharma Inc., Fate Therapeutics, Inc., Bristol-Myers Squibb Company,
ViaCyte, Inc., Celgene Corporation, Aastrom Biosciences, Inc., Acelity
Holdings, Inc., StemCells, Inc., Japan Tissue Engineering Co., Ltd. and
Organogenesis Inc. is also provided in this report.
Pluripotent stem cells are embryonic stem cells that have the
potential to form all adult cell types and help in repairing of damaged tissues
in the human body. An induced pluripotent stem cells, or iPSCs, are taken from
any tissue (usually skin or blood) from a child or an adult and is genetically
modified to behave like pluripotent stem cells or embryonic stem cells.
Download Sample Copy of this Report at: https://www.alliedmarketresearch.com/request-toc-and-sample/1524
iPSCs market is in emerging state
mainly due to its ability to make any cell or tissue the body might need to
encounter wide range of diseases like diabetes, spinal cord injury, leukaemia
or heart disease, these cells can potentially be customized to provide a
perfect genetic match for any patient. Furthermore, these cells are very useful
in understanding the earliest stage of human development and offer the
opportunity to create customized, rejection-proof cells and tissues for
transplantation. Also, government and private sectors are increasing funding
and growing industry that focuses on different research work related to iPSCs
and people are getting more aware about the stem cells through different
organisations. However, factors such as high cost associated with the
reprograming of cells, ethical issues and lengthy processes are impeding the
market growth. Low efficiency, potential tumor risk and incomplete programming
are added factors limiting iPSCs market growth.
The world iPSCs market has been
segmented based on derived cell type, application, end-user and geography.
Based on derived cell type, the market is segmented into hepatocytes,
fibroblasts, keratinocytes, amniotic cells and others. Based on application, the
market is segmented into academic research, drug development and toxicity
testing and regenerative medicine. Based on end-user, the market is segmented
into hospitals and research laboratories. The market is analyzed on the basis
of four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
Product launch, collaboration
& merger, and acquisition are the key strategies adopted by market players.
Healthcare giant such as Fujifilm Holding Corporation has acquired Cellular
Dynamics International, Inc. in March 2015 creating a high growth in iPSCs
market. Also, Juno Therapeutics and Fate Therapeutics collaborated to improve
the products market.
First time buyer? Check offers and discount on this report: https://www.alliedmarketresearch.com/purchase-enquiry/1524
KEY
MARKET BENEFITS:
- Comprehensive
analysis of factors that drive and restrict the growth of the world iPSCs
market is provided in the report.
- The
projections in the report are based on the current market trends and
future market potential in terms of value for the period of 2014-2022.
- Exhaustive
analysis of the world iPSCs market by technique helps in understanding the
different techniques of iPSCs that are currently used along with the
variants that would gain prominence in future.
- Competitive
intelligence of leading manufacturers and distributors of iPSCs helps in
understanding the competitive scenario across various geographies.
- The
key players operating in the global market along their growth strategies
have been provided in the report to understand the competitive outlook of
the market.
- Analysis
of current research and clinical developments within iPSCs market is
provided with key market dynamic factors that helps in understanding the
behaviour of the market.
INDUCED PLURIPOTENT
STEM CELLS MARKET SEGMENT:
The world iPSCs market is
segmented as follows:
By Derived Cell Type
- Hepatocytes
- Fibroblasts
- Keratinocytes
- Amniotic
Cells
- Others
By Application
- Academic
Research
- Drug
Development And Discovery
- Toxicity
Screening
- Regenerative
Medicine
By End-User
- Hospitals
- Research
Laboratories
By Geography
- North
America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Others
- Asia
Pacific
- Japan
- India
- China
- Others
- LAMEA
- Brazil
- UAE
- South
Africa
- Others
Comments
Post a Comment